» Articles » PMID: 34705110

Association Between Number of Abnormal Glucose Values and Severity of Fasting Plasma Glucose in IADPSG Criteria and Maternal Outcomes in Women with Gestational Diabetes Mellitus

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2021 Oct 27
PMID 34705110
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The International Association for Diabetes in Pregnancy Study Group (IADPSG) criteria recommend a single-step diagnostic oral glucose tolerance test (OGTT) for diagnosis of gestational diabetes mellitus (GDM). The aim of this study was to examine the association between the number of abnormal glucose values and levels of FPG with pregnancy outcomes.

Methods: Pregnant women (n=1,044) were screened for GDM at maternity centers in South India using IADPSG criteria. OGTTs were classified based on the number of abnormal glucose values (any one value or more than one value high) and fasting plasma glucose (FPG) values (<92mg/dl,92-100mg/dl,>100mg/dl) and correlated with pregnancy outcomes. Odds ratio were adjusted for age, BMI, gestational week at diagnosis, family history of diabetes, previous history of GDM, gestational week at delivery and birth weight. For macrosomia and large for gestation age, birth weight was excluded from the model.

Results: Risk of caesarean section was significantly higher in women with any one abnormal glucose value (OR: 1.49; 95%CI: 1.07-2.09). This further increased in those with >1 value (OR: 1.35; 95%CI: 0.87-2.10), when compared to women with all values normal. Risk of large for gestation age (LGA) was higher in women with FPG 92-100mg/dl (OR: 1.37; 95%CI: 0.80-2.35) and in those with FPG >100mg/dl (OR: 1.87; 95%CI: 1.04-3.35), compared to those with FPG <92mg/dl.

Conclusions: The risk for poor pregnancy outcomes starts in those with one abnormal value in the OGTT or with FPG >92mg/dl but becomes significantly higher in those with higher abnormal values.

Citing Articles

Perinatal and neonatal outcomes in gestational diabetes: The importance of the number of abnormal values in an oral glucose tolerance test.

Etelainen S, Keikkala E, Lingaiah S, Viljakainen M, MaNnisto T, Pouta A Acta Obstet Gynecol Scand. 2024; 104(1):130-138.

PMID: 39473341 PMC: 11683557. DOI: 10.1111/aogs.14999.


Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial.

Haque M, Tannous W, Herman W, Immanuel J, Hague W, Teede H EClinicalMedicine. 2024; 71():102610.

PMID: 38813447 PMC: 11133791. DOI: 10.1016/j.eclinm.2024.102610.


Dietary Intake and Oral Glucose Tolerance Test Results in Women with Gestational Diabetes.

Chagas L, Torloni M, Silva-Neto L, Dualib P, de Sousa R, Bittencourt J J Clin Med. 2024; 13(10).

PMID: 38792489 PMC: 11122252. DOI: 10.3390/jcm13102948.


Value of Non-Coding RNA Expression in Biofluids to Identify Patients at Low Risk of Pathologies Associated with Pregnancy.

Cordier A, Zerbib E, Favier A, Dabi Y, Darai E Diagnostics (Basel). 2024; 14(7).

PMID: 38611642 PMC: 11011513. DOI: 10.3390/diagnostics14070729.


The CHANGED Score-A New Tool for the Prediction of Insulin Dependency in Gestational Diabetes.

Rostin P, Balke S, Sroka D, Fangmann L, Weid P, Henrich W J Clin Med. 2023; 12(22).

PMID: 38002781 PMC: 10672469. DOI: 10.3390/jcm12227169.

References
1.
OSullivan J, MAHAN C . CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY. Diabetes. 1964; 13:278-85. View